Opti'care protocol: a randomised control trial to evaluate the impact of a mobile antenatal care clinic in isolated rural areas on prenatal follow-up.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
16 02 2023
Historique:
entrez: 16 2 2023
pubmed: 17 2 2023
medline: 22 2 2023
Statut: epublish

Résumé

Rural residence appears to be a factor of vulnerability among pregnant women with poor clinical antenatal care. Our principal objective is to assess the impact of an infrastructure for a mobile antenatal care clinic on the completion of antenatal care for women identified as geographically vulnerable in a perinatal network. Controlled cluster-randomised study in two parallel arms comparing an intervention group with an open-label control group. This study will concern the population of pregnant women who must live in one of the municipalities covered by the perinatal network and considered to be an area of geographic vulnerability. The cluster randomisation will take place according to the municipality of residence. The intervention will be the implementation of pregnancy monitoring by a mobile antenatal care clinic. The completion of antenatal care between the intervention and control groups will be a binary criterion: 1 will be attributed to each antenatal care that includes all visits and supplementary examinations. Sample size has been estimated to be 330 at least with an 80% participation rate.The univariate analyses will compare the follow-up rates (with Fisher's exact test), and all individual characteristics collected (Fisher's exact test, Student's t-test) between the two groups. The multivariate analysis will use a mixed linear model analysis and consider the cluster effect as random; the initial model will include known confounders from the literature, confounders identified in univariate analyses, and the clinically relevant prognostic factors. All of these factors will be taken into account in the model as a fixed effect. The Patient Protection Committee North-West II approved this study on 4 February 2021 (IRB 2020-A02247-32). The results will be the subject of scientific communications and publications. NCT04823104.

Identifiants

pubmed: 36797021
pii: bmjopen-2021-060337
doi: 10.1136/bmjopen-2021-060337
pmc: PMC9936278
doi:

Banques de données

ClinicalTrials.gov
['NCT04823104']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e060337

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Int J Health Geogr. 2012 Aug 20;11:35
pubmed: 22905951
BMC Health Serv Res. 2017 Feb 23;17(1):163
pubmed: 28231830
Acta Obstet Gynecol Scand. 1997 Jan;76(1):1-14
pubmed: 9033238
Acta Obstet Gynecol Scand. 2015 Feb;94(2):156-64
pubmed: 25354758
Trials. 2011 Jun 14;12:151
pubmed: 21672223
Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:162-7
pubmed: 25027267
BMJ Open. 2016 Mar 02;6(3):e009203
pubmed: 26936901
J Rural Health. 2009 Fall;25(4):342-51
pubmed: 19780913
Paediatr Perinat Epidemiol. 2015 Sep;29(5):426-35
pubmed: 26186278
BJOG. 2018 Apr;125(5):587-595
pubmed: 28631308
Health Place. 2011 Sep;17(5):1170-3
pubmed: 21727022
BMC Pregnancy Childbirth. 2011 Feb 11;11:13
pubmed: 21314944
Health Place. 2013 Nov;24:225-33
pubmed: 24177417
J Gynecol Obstet Biol Reprod (Paris). 2001 Feb;30(1):51-8
pubmed: 11240505
Paediatr Perinat Epidemiol. 2008 Jul;22(4):341-9
pubmed: 18578747
BMJ Open. 2020 Dec 13;10(12):e036852
pubmed: 33318106
Cochrane Database Syst Rev. 2013 Feb 28;(2):CD001134
pubmed: 23450532
Am J Obstet Gynecol. 2016 May;214(5):661.e1-661.e10
pubmed: 26645955
CMAJ. 2016 Dec 6;188(17-18):E456-E465
pubmed: 27672220
J Obstet Gynecol Neonatal Nurs. 2011 Mar-Apr;40(2):157-65
pubmed: 21314710
J Rural Health. 2007 Winter;23(1):42-8
pubmed: 17300477

Auteurs

Anne Debost-Legrand (A)

CHU Clermont-Ferrand, CNRS, Clermont Auvergne INP, Institut Pascal, Université Clermont Auvergne, Clermont-Ferrand, France alegrand@chu-clermontferrand.fr.
Réseau de Santé en Périnatalité d'Auvergne, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Guillaume Legrand (G)

Centre Hospitalier Sainte Marie de Clermont-Ferrand, Association Hospitalière Sainte-Marie, Chamalieres, France.

Julie Duclos-Médard (J)

Réseau de Santé en Périnatalité d'Auvergne, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Juliette Thomazet (J)

Réseau de Santé en Périnatalité d'Auvergne, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Marine Pranal (M)

CHU Clermont-Ferrand, CNRS, Clermont Auvergne INP, Institut Pascal, Université Clermont Auvergne, Clermont-Ferrand, France.

Eric Langlois (E)

UMR Territoires, AgroparisTech, INRA, Irstea, VetAgro Sup, Universite Clermont Auvergne, Clermont-Ferrand, France.

Charline Mourgues (C)

Direction de la Recherche Clinique et de l'Innovation, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Françoise Vendittelli (F)

CHU Clermont-Ferrand, CNRS, Clermont Auvergne INP, Institut Pascal, Université Clermont Auvergne, Clermont-Ferrand, France.
Réseau de Santé en Périnatalité d'Auvergne, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH